{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:15:56Z","timestamp":1794356156062,"version":"4.9.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2024-IRB-A-01\/01"],"award-info":[{"award-number":["2024-IRB-A-01\/01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.neuroscience.2025.03.050","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T06:00:19Z","timestamp":1743746419000},"page":"442-450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Chenodeoxycholic Acid-Mediated neuroprotection via \u03b1-synuclein and BDNF Modulation in MPTP-Induced mouse model of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"573","author":[{"given":"Mehwish","family":"Mehreen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehak","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huraira","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8692-3161","authenticated-orcid":false,"given":"Aneeqa","family":"Noor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Mumtaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saima","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2025.03.050_b0005","first-page":"653","article-title":"Ursodeoxycholic and tauroursodeoxycholic acids as antiapoptotic agents: modulation of Parkinson\u2019s disease","volume":"1","author":"Abdelkader","year":"2020","journal-title":"Diagnosis Manag Park Dis Neurosci Park Dis"},{"key":"10.1016\/j.neuroscience.2025.03.050_b0010","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2016.00263","article-title":"Bile acids in neurodegenerative disorders","volume":"8","author":"Ackerman","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuroscience.2025.03.050_b0015","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14521","article-title":"Sleep disorders cause Parkinson\u2019s disease or the reverse is true: Good GABA good night","volume":"30","author":"Al-kuraishy","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"43","key":"10.1016\/j.neuroscience.2025.03.050_b0020","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1007\/s10571-023-01350-8","article-title":"(2023a) Parkinson\u2019s Disease Risk and Hyperhomocysteinemia: The Possible Link","volume":"436","author":"Al-kuraishy","year":"2023","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuroscience.2025.03.050_b0025","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/jnr.25171","article-title":"SARS-COV-2 infection and Parkinson\u2019s disease: Possible links and perspectives","volume":"101","author":"Al-kuraishy","year":"2023","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuroscience.2025.03.050_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102075","article-title":"The conceivable role of prolactin hormone in Parkinson disease: The same goal but with different ways","volume":"91","author":"Al-kuraishy","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neuroscience.2025.03.050_b0035","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1007\/s12035-023-03727-8","article-title":"The Molecular Pathway of p75 Neurotrophin Receptor (p75NTR) in Parkinson\u2019s Disease: The Way of New Inroads","volume":"61","author":"Ali","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuroscience.2025.03.050_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jcmm.18368","article-title":"BDNF\/TrkB activators in Parkinson\u2019s disease: A new therapeutic strategy","volume":"28","author":"Ali","year":"2024","journal-title":"J. Cell Mol. Med."},{"issue":"61","key":"10.1016\/j.neuroscience.2025.03.050_b0045","first-page":"341","article-title":"(2023) Role of Brain Liver X Receptor in Parkinson\u2019s Disease: Hidden Treasure and Emerging Opportunities","volume":"611","author":"Alnaaim","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuroscience.2025.03.050_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24101992","article-title":"Chenodeoxycholic acid ameliorates AlCl3-induced Alzheimer\u2019s disease neurotoxicity and cognitive deterioration via enhanced insulin signaling in rats","volume":"24","author":"Bazzari","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.neuroscience.2025.03.050_b0055","first-page":"4240","article-title":"Effect of Intrastriatal 6-OHDA Lesions on Extrastriatal Brain Structures in the Mouse","volume":"55","author":"Becker","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuroscience.2025.03.050_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/brb3.2251","article-title":"Brain-derived neurotrophic factor attenuates cognitive impairment and motor deficits in a mouse model of Parkinson\u2019s disease","volume":"11","author":"Chang","year":"2021","journal-title":"Brain Behav."},{"key":"10.1016\/j.neuroscience.2025.03.050_b0065","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1080\/1028415X.2020.1859729","article-title":"Tauroursodeoxycholic acid (TUDCA) is neuroprotective in a chronic mouse model of Parkinson\u2019s disease","volume":"25","author":"Cuevas","year":"2022","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.03.050_b0070","doi-asserted-by":"crossref","first-page":"457","DOI":"10.30802\/AALAS-JAALAS-21-000125","article-title":"Use of Ketamine or Xylazine to Provide Balanced Anesthesia with Isoflurane in C57BL\/6J Mice","volume":"61","author":"David","year":"2022","journal-title":"J. Am. Assoc. Lab. Anim. Sci."},{"key":"10.1016\/j.neuroscience.2025.03.050_b0075","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-1-4939-1050-2_3","article-title":"Tissue processing and hematoxylin and eosin staining","volume":"1180","author":"Feldman","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neuroscience.2025.03.050_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2020.00356","article-title":"Modeling Parkinson\u2019s Disease With the Alpha-Synuclein Protein","volume":"11","author":"G\u00f3mez-Benito","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuroscience.2025.03.050_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21175982","article-title":"Bile acid signaling in neurodegenerative and neurological disorders","volume":"21","author":"Grant","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2025.03.050_b0090","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s12565-018-0457-7","article-title":"Neuroprotective effect of crocin on substantia nigra in MPTP-induced Parkinson\u2019s disease model of mice","volume":"94","author":"Haeri","year":"2019","journal-title":"Anat. Sci. Int."},{"key":"10.1016\/j.neuroscience.2025.03.050_b0095","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bbr.2014.04.022","article-title":"Effects of ceftriaxone on the behavioral and neuronal changes in an MPTP-induced Parkinson\u2019s disease rat model","volume":"268","author":"Ho","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuroscience.2025.03.050_b0100","doi-asserted-by":"crossref","first-page":"905","DOI":"10.5551\/jat.RV17055","article-title":"Cerebrotendinous xanthomatosis: Molecular pathogenesis, clinical spectrum, diagnosis, and disease-modifying treatments","volume":"28","author":"Koyama","year":"2021","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.neuroscience.2025.03.050_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117319","article-title":"Total Glucosides of White Paeony Capsule ameliorates Parkinson\u2019s disease-like behavior in MPTP-induced mice model by regulating LRRK2\/alpha-synuclein signaling","volume":"319","author":"Li","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.neuroscience.2025.03.050_b0110","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1124\/pr.113.008201","article-title":"Bile acid signaling in metabolic disease and drug therapy","volume":"66","author":"Li","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuroscience.2025.03.050_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2018.00241","article-title":"Investigation of behavioral dysfunctions induced by monoamine depletions in a mouse model of Parkinson\u2019s disease","volume":"12","author":"Li","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.03.050_b0120","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s12640-018-9869-3","article-title":"Naringenin Decreases \u03b1-Synuclein Expression and Neuroinflammation in MPTP-Induced Parkinson\u2019s Disease Model in Mice","volume":"33","author":"Mani","year":"2018","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuroscience.2025.03.050_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mcn.2019.01.003","article-title":"Neurotoxic effects of MPTP on mouse cerebral cortex: Modulation of neuroinflammation as a neuroprotective strategy","volume":"96","author":"Mendes","year":"2019","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.03.050_b0130","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/mds.21010","article-title":"Behavioral models of Parkinsons disease in rodents: A new look at an old problem","volume":"21","author":"Meredith","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuroscience.2025.03.050_b0135","unstructured":"Mhyre TR, Nw R, Boyd JT, et al (2012) Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease."},{"key":"10.1016\/j.neuroscience.2025.03.050_b0140","first-page":"1","article-title":"Assessment of spontaneous alternation, novel object recognition and limb clasping in transgenic mouse models of amyloid-\u03b2 and tau neuropathology","volume":"2017","author":"Miedel","year":"2017","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.neuroscience.2025.03.050_b0145","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s00455-015-9612-7","article-title":"Alpha-Synuclein Pathology in Sensory Nerve Terminals of the Upper Aerodigestive Tract of Parkinson\u2019s Disease Patients","volume":"30","author":"Mu","year":"2015","journal-title":"Dysphagia"},{"key":"10.1016\/j.neuroscience.2025.03.050_b0150","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.neuroscience.2014.07.046","article-title":"Neuroprotective effect of metformin in MPTP-induced Parkinson\u2019s disease in mice","volume":"277","author":"Patil","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2025.03.050_b0155","doi-asserted-by":"crossref","first-page":"15918","DOI":"10.1073\/pnas.1205102109","article-title":"Progressive dopaminergic cell loss with unilateral-to-bilateral progression in a genetic model of Parkinson disease","volume":"109","author":"Rousseaux","year":"2012","journal-title":"PNAS"},{"key":"10.1016\/j.neuroscience.2025.03.050_b0160","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/jnc.15699","article-title":"Neurochemical, histological, and behavioral profiling of the acute, sub-acute, and chronic MPTP mouse model of Parkinson\u02bcs disease","volume":"164","author":"Santoro","year":"2023","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuroscience.2025.03.050_b0165","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0166-4328(01)00309-6","article-title":"Behavioral phenotyping of the MPTP mouse model of Parkinson\u2019s disease","volume":"125","author":"Sedelis","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuroscience.2025.03.050_b0170","article-title":"Use of the open field maze to measure locomotor and anxiety-like behavior in mice","volume":"1\u20136","author":"Seibenhener","year":"2015","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.neuroscience.2025.03.050_b0175","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pneurobio.2006.11.009","article-title":"Advances in the treatment of Parkinson\u2019s disease","volume":"81","author":"Singh","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuroscience.2025.03.050_b0180","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.00157","article-title":"The Effect of Estrogen Replacement Therapy on Alzheimer\u2019s Disease and Parkinson\u2019s Disease in Postmenopausal Women: A Meta-Analysis","volume":"14","author":"Song","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.03.050_b0185","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1096\/fj.05-5106com","article-title":"Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP\u2010induced neurotoxicity: role of TNF\u2010\u03b1 1","volume":"20","author":"Sriram","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.neuroscience.2025.03.050_b0190","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: A new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2025.03.050_b0195","doi-asserted-by":"crossref","unstructured":"Sturchio A, Rocha EM, Kauffman MA, et al (2024) Recalibrating the Why and Whom of Animal Models in Parkinson Disease: A Clinician\u2019s Perspective. Brain Sci 2024, Vol 14, Page 151 14:151. doi: 10.3390\/BRAINSCI14020151.","DOI":"10.3390\/brainsci14020151"},{"key":"10.1016\/j.neuroscience.2025.03.050_b0200","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1142\/S0192415X23500167","article-title":"Sophora alopecuroides Alleviates Neuroinflammation and Oxidative Damage of Parkinson\u2019s Disease In Vitro and In Vivo","volume":"51","author":"Sun","year":"2023","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.neuroscience.2025.03.050_b0205","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0304-3940(93)90105-T","article-title":"MPTP neurotoxicity to cerebellar Purkinje cells in mice","volume":"150","author":"Takada","year":"1993","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuroscience.2025.03.050_b0210","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1413520","article-title":"Mogroside V and mogrol: unveiling the neuroprotective and metabolic regulatory roles of Siraitia grosvenorii in Parkinson\u2019s disease","volume":"15","author":"Tang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuroscience.2025.03.050_b0220","article-title":"Robust nuclease-dead S. aureus dCas9-mediated alpha-synuclein knockdown in substantia nigra in a humanized mouse model of Parkinson\u2019s disease","author":"Torres","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.neuroscience.2025.03.050_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.112047","article-title":"Psychomotor retardation in depression: A critical measure of the forced swim test","volume":"372","author":"Unal","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuroscience.2025.03.050_b0230","doi-asserted-by":"crossref","first-page":"e3988","DOI":"10.21769\/BioProtoc.3988","article-title":"Transcardiac Perfusion of the Mouse for Brain Tissue Dissection and Fixation","volume":"11","author":"Wu","year":"2021","journal-title":"Bio-Protocol"},{"key":"10.1016\/j.neuroscience.2025.03.050_b0235","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s11011-022-01153-8","article-title":"Neuroprotective effect of hyperoside in MPP+\/MPTP -induced dopaminergic neurodegeneration","volume":"38","author":"Xu","year":"2023","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuroscience.2025.03.050_b0240","first-page":"4989","article-title":"Neuroprotective effects of lithium on a chronic MPTP mouse model of Parkinson\u2019s disease via regulation of \u03b1\u2011synuclein methylation","volume":"19","author":"Zhao","year":"2019","journal-title":"Mol. Med. Rep."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452225002520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452225002520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T21:46:31Z","timestamp":1762292791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452225002520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":47,"alternative-id":["S0306452225002520"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.03.050","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chenodeoxycholic Acid-Mediated neuroprotection via \u03b1-synuclein and BDNF Modulation in MPTP-Induced mouse model of Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.03.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}